Retour
Onconetix Inc (ONCO) Gagner
Graphique du cours de l'action ONCO
ONCO Gagner
Onconetix Inc
$0.56
-6.81%
$-0.04
À partir d'aujourd'hui :Mar 24, 15:05:30 GMT-4
Statistiques clés
Clôture préc.
$0.6017
Prix d'ouverture
$0.61
Plage de la journée
$0.5606 - $0.69
Plage de 52 semaines
$0.44 - $14.87
Volume
369.5K
Volume moyen
335.3K
Rendement en dividend
--
BPA (TTM)
-342.64
Capitalisation boursière
$874.6K
Qu’est-ce que ONCO ?
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company is headquartered in Cincinnati, Ohio and currently employs 5 full-time employees. The company went IPO on 2022-02-18. The firm owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.